Annotation Detail for NTSR2
Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04080 | Neuroactive ligand-receptor interaction |
Pathway ID | Pathway Name |
---|
| Signaling by GPCR |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of NTSR2 mRNA | affects expression | 21346803
|
D002713 |
Chlorine |
Chlorine results in decreased expression of NTSR2 mRNA | decreases expression | 18636392
|
D002713 |
Chlorine |
[Ozone co-treated with Chlorine] affects the expression of NTSR2 mRNA | affects cotreatment|affects expression | 18636392
|
D003993 |
Dibutyl Phthalate |
Dibutyl Phthalate results in increased expression of NTSR2 mRNA | increases expression | 15620428
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in decreased expression of NTSR2 mRNA | affects cotreatment|decreases expression | 17183730
|
D010126 |
Ozone |
[Ozone co-treated with Chlorine] affects the expression of NTSR2 mRNA | affects cotreatment|affects expression | 18636392
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in decreased expression of NTSR2 mRNA | affects cotreatment|decreases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.95 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.25 | 19490988 |
MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
4.67 | 20601635 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.49 | 15513908 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.75 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.83 | 17497229 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.61 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.71 | 17854713 16373670 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 18177632 15238991 18558336 17507914 19232924 17157402 18940202 20603192 16609825 18316065 18775368 19460635 18985861 18396377 17688650 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.21 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.59 | 8888407 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.93 | 14754758 18417511 19059883 18315731 16777450 17626835 15516495 |
MESH:D002100 |
Cachexia |
|
Ozone |
5.20 | 16183385 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
1.78 | 16705839 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.98 | 6135515 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.80 | 20734317 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 8888407 16575769 17688650 |
MESH:D003456 |
Cryptorchidism |
|
Dibutyl Phthalate |
5.83 | 16037377 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.44 | 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
4.18 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
4.18 | 19641884 1733752 |
MESH:D004417 |
Dyspnea |
|
Chlorine |
5.14 | 20016425 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.40 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.57 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.44 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.07 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.87 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.71 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.53 | 3659116 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.62 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.41 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.51 | 18558336 8888407 |
MESH:D005739 |
Gas Poisoning |
|
Chlorine |
5.53 | 20016425 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.33 | 17688650 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
5.04 | 16612254 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.24 | 16705839 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.19 | 17596541 16294345 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.24 | 7678174 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.72 | 2876786 2876784 6135515 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.57 | 8266340 19066396 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.78 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Ozone |
4.26 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
2.10 | 8597069 7614698 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.63 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.41 | 18803445 18765137 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.35 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.31 | 17596541 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.32 | 18551238 7678174 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.32 | 16359493 8888407 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.74 | 16049721 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.55 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.86 | 18381685 18929643 18007984 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.29 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.06 | 11422049 12752131 |
MESH:D012120 |
Respiration Disorders |
|
Chlorine |
5.73 | 18579056 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.53 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.10 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.63 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.63 | 11044598 15475178 3137016 11738929 14763951 16876388 17978042 1511512 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.02 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.06 | 12833885 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.75 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.98 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.39 | 16049721 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.06 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.78 | 10091137 |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB01106 |
partial antagonist |
Levocabastine |
Histamine H1 Antagonists;Histamine H1 Antagonists, Non-Sedating |